LENZ Therapeutics, Inc.

YTD

ALL

Trade LENZ Therapeutics, Inc. 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LENZ

LENZ Therapeutics, Inc. is a pre-commercial biopharmaceutical company, which focuses on the development and commercialization of innovative therapies to improve vision. It offers eye drop product treatment for presbyopia.

CEO

Evert B. Schimmelpennink

CEOEvert B. Schimmelpennink

Employees

Employees42

Headquarters

Solana Beach, California

HeadquartersSolana Beach, California

Founded

2013

Founded2013

Employees

Employees42

LENZ Key Statistics

Market cap

864.79M

Market cap864.79M

Price-Earnings ratio

-16.23

Price-Earnings ratio-16.23

Dividend yield

—

Dividend yield—

Average volume

1.21M

Average volume1.21M

High today

$32.01

High today$32.01

Low today

$29.80

Low today$29.80

Open price

$31.00

Open price$31.00

Volume

414.28K

Volume414.28K

52 Week high

$50.40

52 Week high$50.40

52 Week low

$16.54

52 Week low$16.54

Analyst ratings

100%

of 8 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own LENZ. This list is generated using Robinhood data, and it’s not a recommendation.

LENZ Therapeutics, Inc.

Trade LENZ Therapeutics, Inc. 24 hours a day, five days a week on Robinhood.

LENZ Therapeutics, Inc. is a pre-commercial biopharmaceutical company, which focuses on the development and commercialization of innovative therapies to improve vision. It offers eye drop product treatment for presbyopia. Show more

LENZ Key Statistics

Analyst ratings

100%

People also own

LENZ Therapeutics, Inc. is a pre-commercial biopharmaceutical company, which focuses on the development and commercialization of innovative therapies to improve vision. It offers eye drop product treatment for presbyopia.